Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

CheckMate 9ER Investigators

Research output: Contribution to journalArticlepeer-review

284 Scopus citations

Fingerprint

Dive into the research topics of 'Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences